Genmab A/S (Nasdaq: GMAB) today announced that over 20 abstracts evaluating epcoritamab-bysp (EPKINLY®), a subcutaneously administered T-cell engaging bispecific antibody, will be presented at the 66th Annual Meeting of the American Society of Hematology (ASH), taking place December 7-10, 2024,…
ELIQUENT Life Sciences, a global regulatory consulting firm, is pleased to announce the addition of Shelley Gandhi, a renowned pharmacovigilance (PV) expert, to its team. This strategic hire strengthens ELIQUENT’s leadership in regulatory and quality services and underscores the firm’s…
Immunis, Inc., a clinical-stage biotechnology company focused on developing innovative secretomes for age-related diseases and immune dysfunction, has launched non-terminal safety studies for canine muscle atrophy in collaboration with VetBio Partners, LLC. This follows the successful preclinical results of Immunis’…
LumiThera Inc., a medical device company specializing in photobiomodulation (PBM) therapy for ocular conditions, today announced that the U.S. Food and Drug Administration (FDA) has granted marketing authorization for its Valeda® Light Delivery System. The system is approved for the…
GeneDx (Nasdaq: WGS), a leader in leveraging genomic insights to improve health outcomes, today announced its scientific contributions for the 2024 American Society of Human Genetics (ASHG) Annual Meeting. GeneDx will present data across six platform sessions and five posters,…
Inquis Medical, an innovator in advanced thrombectomy systems, today announced the successful closure of its oversubscribed $40 million Series B financing round. The round was led by Marshall Wace, a globally renowned investment firm, with strong support from existing investors…
Tempus AI, Inc. (NASDAQ: TEM), a technology company at the forefront of using AI to advance precision medicine and patient care, today reported its financial results for the third quarter of 2024. The company also announced it has reached an…
BlueWind Medical, Ltd., a leader in implantable Tibial Neuromodulation (iTNM) and developer of the Revi® System for treating urge urinary incontinence (UUI), announced that the Centers for Medicare & Medicaid Services (CMS) has finalized a positive payment adjustment for the…
Universal Health Services (NYSE: UHS) has been named one of the Top 100 Employers of Choice in the 2024 American Opportunity Index, which evaluates how effectively companies develop talent and enhance employee careers. UHS ranks #1 in the ‘Medical Care…
Ria Health, a national leader in telehealth treatment for Alcohol Use Disorder (AUD), has announced the appointment of Dr. Martin Rosenzweig to its Board of Directors. With over 25 years of experience in managed care, psychiatric disorders, and substance use…
